READ: ARW ON CGT

Business-teamwork-GettyImages-1345654453 Cell & Gene Manufacturing Risk Vs. Benefit: How It’s Reflected In Our FDA Interactions

Though many important topics of conversation were broached during the 2022 FDA CMC townhalls, there were two within which the industry is working to define how much is too much or not yet enough. In the following two parts of this article, I’ll briefly unpack some of the high-level best practices offered by the FDA to help you work your way towards “just right.”

  • 4 “Hot Takes” On Cell & Gene Therapy Manufacturing From Advanced Therapies Week 2023

    There is truly no article more difficult to write than a takeaway article from a conference. But as I recently spent the past week attending various panels and hearing different perspectives at Phacilitate’s Advanced Therapies Week, I wanted to attempt to do “the impossible” (for me): Share four of the burning manufacturing takeaways that jumped out at me most during the week.

WATCH: ARW ON RNA

  • Harry Potter Meets mRNA | ARW On RNA Ep01

    Hosted by Cell & Gene Collaborative's Director Anna Rose Welch, ARW on RNA puts a creative spin on the emerging mRNA + RNA therapeutics industry. Here, in Episode 1, Welch draws a few connections between the magical world of Harry Potter and the challenging scientific work mRNA companies are doing today to explore and/or broaden mRNA's therapeutic potential in a variety of indications.

  • Introducing ARW On RNA!

    Hosted by Cell & Gene Collaborative's Director Anna Rose Welch, ARW on RNA puts a creative spin on the emerging mRNA + RNA therapeutics industry. How can the game of RISK, Harry Potter, and Michelangelo's David bring clarity to the innerworkings of the mRNA + RNA therapeutics industry? Join us for a wild ride through pop culture and its potential to further our understanding of these therapeutics.

Subscribe To ARW's Newsletter

ABOUT CELL & GENE COLLABORATIVE

We are an editorial resource and virtual peer-group bringing together the best and brightest manufacturing minds in the advanced therapies industry. We cue the conversations and provide an off-the-beaten path forum for manufacturing professionals to meet their peers and learn from each other — and have a great time doing it.

MEET ARW

Anna RoseAnna Rose Welch is the director of Cell & Gene Collaborative. In this role, she is forging close relationships with the leading voices and organizations in the cell and gene therapy manufacturing sphere. This includes establishing a peer group comprising Cell & Gene company manufacturing SMEs, conducting interviews and hosting interactive roundtables on the evolving manufacturing paradigm, and authoring thought leadership articles and blog posts via the Cell & Gene Collaborative blog.